Daily low-dose aspirin found to have no effect on healthy life span in older people

In a clinical trial to determine the effects of daily low-dose aspirin in healthy older adults without previous cardiovascular events, aspirin did not prolong healthy, independent living free of dementia or physical disability. These findings from the ASPirin in Reducing Events in the Elderly (ASPREE) trial, partially supported by the National Institutes of Health, were published online on September 16, 2018 in three papers in The New England Journal of Medicine.

What feeling does this article give you?

#hashtags to follow:

ASPirin [+]    Reducing Events [+]    ASPREE [+]    National Institutes of Health [+]    September 16 [+]   

More #news: